| Financial Year |
March 31 2022 |
| Monetary Funds |
403,275,743.26 |
| Held-for-trading Financial Assets |
781,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
22,805,197.51 |
| Advances to Suppliers |
6,086,948.88 |
| Other Receivables |
585,920,536.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
10,793,986.87 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
25,608,278.39 |
| Total Current Assets |
1,055,271,691.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
201,653,557.71 |
| Investment Properties |
-- |
| Fixed Assetes |
546,796,084.38 |
| Under-construction Projects |
373,109,335.79 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
369,859,727.41 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
45,609,047.48 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
9,506,217.00 |
| Sub-Total of Non-Current Assets |
1,582,390,940.93 |
| Total Assets |
2,637,662,632.55 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
268,611,577.35 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,620,885.19 |
| Taxes Payable |
24,266,961.86 |
| Interest Payable |
435,943.82 |
| Dividend Payable |
545,734.15 |
| Other payables |
127,506,413.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
63,849,401.19 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
541,398,186.32 |
| Long-term Loans |
173,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
176,613,169.50 |
| Total Liabilities |
718,011,355.82 |
| Paid-In Capital(Or Share Stock) |
1,024,805,419.00 |
| Capital Surplus |
2,269,275,000.32 |
| Surplus Reserve |
136,317,641.92 |
| LESS:Treasury Stock |
30,200,960.75 |
| Undistributed Profits |
-1,484,106,806.90 |
| Minority Stockholder's Interest |
2,444,577.15 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,917,206,699.58 |
| Owner's Equity（Stockholder's Equity） |
1,919,651,276.73 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,637,662,632.55 |
